FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

JOHNSON MICHAEL 		2. Issuer Name and Ticker or Trading Symbol

HERBALIFE LTD. [ HLF ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Executive Chairman
(Last)          (First)          (Middle)

800 W. OLYMPIC BLVD., SUITE #406 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/11/2017
(Street)

LOS ANGELES, CA 90015
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/11/2017     M    132416   A $22.94   2080700   D    
Common Stock   12/11/2017     D (1)    43513   D $69.81   2037187   D    
Common Stock   12/11/2017     F (1)    49120   D $69.81   1988067   D    
Common Stock   12/11/2017     M    210648   A $53.29   2198715   D    
Common Stock   12/11/2017     D (2)    160800   D $69.81   2037915   D    
Common Stock   12/11/2017     F (2)    27542   D $69.81   2010373   D    
Common Stock   12/11/2017     M    327868   A $44.79   2338241   D    
Common Stock   12/11/2017     D (3)    210360   D $69.81   2127881   D    
Common Stock   12/11/2017     F (3)    64924   D $69.81   2062957   D    
Common Stock                  35340   I   Beneficially owned through a trust for his child  
Common Stock                  113122   I   Beneficially owned through Michael O. Johnson IRA  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right   $22.94   12/11/2017     M         132416    5/7/2013   5/7/2020   Common Stock   132416   $0.00   0   D    
Stock Appreciation Right   $53.29   12/11/2017     M         210648    5/18/2014   5/18/2021   Common Stock   210648   $0.00   0   D    
Stock Appreciation Right   $44.79   12/11/2017     M         327868    5/31/2015   5/31/2022   Common Stock   327868   $0.00   0   D    

Explanation of Responses:
(1)  The reporting person received 39,783 shares of common stock upon the net exercise of 132,416 stock appreciation rights ("SARS"). The reporting person forfeited 43,513 shares of common stock underlying such SARS in payment of the exercise price and 49,120 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.
(2)  The reporting person received 22,306 shares of common stock upon the net exercise of 210,648 SARS. The reporting person forfeited 160,800 shares of common stock underlying such SARS in payment of the exercise price and 27,542 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.
(3)  The reporting person received 52,584 shares of common stock upon the net exercise of 327,868 SARS. The reporting person forfeited 210,360 shares of common stock underlying such SARS in payment of the exercise price and 64,924 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 11, 2017 of $69.81.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
JOHNSON MICHAEL
800 W. OLYMPIC BLVD., SUITE #406
LOS ANGELES, CA 90015 		X
Executive Chairman

Signatures
/s/ Eileen Uy, Attorney-in-Fact for Michael O. Johnson 12/13/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Herbalife (NYSE:HLF)
過去 株価チャート
から 3 2024 まで 4 2024 Herbalifeのチャートをもっと見るにはこちらをクリック
Herbalife (NYSE:HLF)
過去 株価チャート
から 4 2023 まで 4 2024 Herbalifeのチャートをもっと見るにはこちらをクリック